Prostate Cancer
Around 32,000 men in the UK are diagnosed with prostate cancer each year. It differs from most other cancers in the body, in that small areas of cancer within the prostate are very common and may not grow or cause any problems for many years. This new edition of the book has been heavily updated and includes information on new treatments available.
CHF 18.50
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V105:
Folgt in ca. 15 Arbeitstagen
Produktdetails
Weitere Autoren: Moffat, Leslie (Consultant Urological Surgeon and Honorary Senior Lecturer, University of Aberdeen)
- ISBN: 978-0-19-957393-6
- EAN: 9780199573936
- Produktnummer: 5490354
- Verlag: Oxford University Press
- Sprache: Englisch
- Erscheinungsjahr: 2010
- Seitenangabe: 120 S.
- Masse: H19.5 cm x B13.0 cm x D0.7 cm 128 g
- Auflage: 2 Revised edition
- Abbildungen: Various 2-colour line drawings and halftones
- Gewicht: 128
- Sonstiges: General (US: Trade)
Über den Autor
Professor Malcolm Mason is an Oncologist with a special interest in prostate cancer. He has been closely involved in clinical trials in prostate cancer for the Medical Research Council for over 18 years, and he has had a research programme in Cardiff University into this disease since 1997. He qualified in London at St Bartholomew's Hospital, and trained in Oncology at the Royal Marsden Hospital, London. He moved to Cardiff in 1992. He is also past-Chairman of theBritish Prostate Group.In 2009, Professor Mason was appointed the Chairman of the National cancer Research Institute's Prostate Cancer Clinical Studies Group, the main UK group responsible for developing and overseeing clinical trials in prostate cancer in the UK.Mr Leslie Moffat trained in Edinburgh and Glasgow. He published the largest study of LHRH analogues Chairman of Scottish Urological Cancer Audit, the largest of its kind in the world.
Bewertungen
Anmelden